In Blow To Sanofi, Judge Refuses To Bar Allegra Generics

Law360, New York (January 30, 2006, 12:00 AM EST) -- Still recovering from slumped sales of its allergy treatment Allegra, French drug maker Sanofi-Aventis was dealt another blow in federal court Friday when a judge denied a motion by the company to enjoin generic rivals from marketing the drug.

Albany Molecular Research Inc. (AMRI), a partner of Sanofi-Aventis, acknowledged its disappointment with Judge Joseph A. Greenwald Jr.’s refusal to issue a preliminary injunction against four generic drug makers in the U.S. District Court for New Jersey.

“While we are disappointed in the ruling issued today, we...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.